ImmunoPrecise Antibodies Ltd. filed a 6-K form report on June 10, 2024, to comply with SEC regulations. The filing is a routine report for foreign private issuers and does not indicate any significant event.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.